Integrated Biopharma Inc Q2 FY2023 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2023 Q2 Call date: 2023-02-10 Concluded

Quarter scorecard

Revenue

$12.25M

-16% YoY

Diluted EPS

$0.03

+0% YoY

Gross margin

8.7%

-3.3 pp YoY

Net income

-105.3% YoY

Contract Manufacturing $11.68M

-16.9%

Other Nutraceutical Business $572,000

+7.5%